Literature DB >> 33794532

Effects of Yoga on Phase Angle and Quality of Life in Patients with Breast Cancer: A Randomized, Single-Blind, Controlled Trial.

Sibel Eyigör1, Sebnem Apaydin2, Hilal Yesil3, Goksel Tanıgor1, Derya Hopanci Bicakli4.   

Abstract

INTRODUCTION: Phase angle (PA), a parameter that is obtained from body composition analysis, is an indicator of cellular health status. A lower PA in cancer patients can lead to a decrease in functional status and quality of life (QoL) and increased mortality. Studies have shown that physical activity increases PA. In this study, we aimed to examine the effects of Hatha yoga on PA, body composition, and QoL in patients with breast cancer.
METHODS: Thirty-one patients were randomized into the yoga (group 1, n = 15) and the control group (group 2, n = 16). Hatha yoga was practiced twice a week for 10 weeks in the intervention group. The PA of the patients was assessed using a body analysis instrument, and QoL was evaluated with an EORTC QLQ questionnaire both before treatment and at week 10.
RESULTS: Group 1 had significant improvements in the posttreatment EORTC QLQ functional and global scores (p < 0.05). In group 2, a significant improvement was observed in the EORTC QLQ symptom subscale (p = 0.035). PA values did not show any improvements in both groups (p > 0.05). Comparison of the 2 groups revealed no differences.
CONCLUSION: Yoga may have beneficial effects on QoL in patients with breast cancer but does not have a significant effect on PA. There is a need for further studies to make a definitive statement.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Body composition; Breast cancer; Hatha yoga; Phase angle; Quality of life

Mesh:

Year:  2021        PMID: 33794532     DOI: 10.1159/000515494

Source DB:  PubMed          Journal:  Complement Med Res        ISSN: 2504-2092            Impact factor:   1.211


  1 in total

Review 1.  Bioelectrical Phase Angle in Patients with Breast Cancer: A Systematic Review.

Authors:  Delia Morlino; Iolanda Cioffi; Maurizio Marra; Olivia Di Vincenzo; Luca Scalfi; Fabrizio Pasanisi
Journal:  Cancers (Basel)       Date:  2022-04-15       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.